Mode
Text Size
Log in / Sign up

Multiple-staged excision reduces major wound complications and recurrence in congenital melanocytic neviMultiple staged excision reduces complications for congenital melanocytic nevi

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider multiple-staged excision for congenital melanocytic nevi to potentially reduce wound complications and recurrence.

This meta-analysis evaluated the outcomes of multiple-staged excision compared to single-stage excision for patients with congenital melanocytic nevi (CMN). The analysis included a total of 578 patients to compare surgical techniques and associated clinical outcomes.

Key findings indicate that multiple-staged excision is associated with a lower incidence of major wound complications (OR 0.54; 95% CI 0.30-0.97, p = 0.04) and a lower recurrence rate (OR 0.45; 95% CI 0.22-0.93, p = 0.03). Additionally, multiple-staged excision was associated with shorter scar lengths (MD -0.32 mm; 95% CI -0.52 to -0.12, p = 0.002) and narrower scar widths (MD -0.04 mm; 95% CI -0.09 to -0.01, p = 0.04). No significant differences were found regarding cosmetic satisfaction (OR 1.07) or patient satisfaction (OR 1.29).

The authors note that the evidence is limited by a lack of direct comparative data. While the results suggest that multiple-staged excision may offer advantages in safety and efficacy for the excision and reconstruction of CMN, the findings represent an association rather than a confirmed superiority of one method over the other.

Living with a congenital melanocytic nevus (CMN) often means facing a difficult choice about surgery. Because these birthmarks can grow or change, the way a surgeon removes them is critical for both safety and the final look of the skin. New data suggests that breaking the surgery into multiple stages might offer a safer path for patients.

Researchers looked at data from 578 patients to compare a multi-staged excision to a single-stage procedure. They found that the multi-staged approach led to fewer major wound complications and a lower rate of the lesion coming back. Additionally, patients who underwent the staged process ended up with shorter and narrower scars.

While the physical results like scar size and complication rates were better with staged surgery, patient and cosmetic satisfaction scores were similar between both groups. Because there is still limited direct evidence comparing these two methods, patients should talk to their doctors to decide which surgical path fits their specific needs.

What this means for you:
Staged surgery for congenital melanocytic nevi can result in fewer complications and smaller scars.

Common questions

What are the benefits of a multi-staged excision?

A multi-staged excision can lead to a lower incidence of major wound complications and a lower rate of lesion recurrence. It also results in shorter scar lengths and narrower scar widths compared to a single-stage procedure.

Does the surgical method change how satisfied patients are?

The data showed no significant difference in cosmetic satisfaction or overall patient satisfaction between those who had a multi-staged excision and those who had a single-stage excision.

Is it safer to have the surgery in stages?

The study found a lower incidence of major wound complications in the multi-staged excision group. However, because there is limited direct comparative evidence, you should discuss the safest option for your specific case with your doctor.

Study Details

Study typeMeta analysis
Sample sizen = 578
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
AIM: Systematic evidence comparing multiple-staged and single-stage excision strategies for the excision and reconstruction of congenital melanocytic nevi (CMN) remains limited. Because direct comparative evidence remains scarce, we pooled available studies to determine whether multiple-staged excision differs from single-stage excision in postoperative complications, recurrence, scar outcomes, and satisfaction after CMN reconstruction. METHODS: To retrieve comparative evidence on surgical strategies for CMN, a systematic literature search was conducted across PubMed, Embase, the Cochrane Library, Web of Science, CNKI, VIP, and Wanfang databases. The retrieval covered all records available from the establishment of each database through 31 October 2025. The prespecified outcomes were major wound complications, lesion recurrence, cosmetic satisfaction, patient satisfaction, postoperative scar length, and scar width. After eligible studies were selected, relevant data were extracted, methodological quality was assessed, and quantitative synthesis was carried out using Review Manager (version 5.3, Cochrane Collaboration). RESULTS: Seven retrospective cohort studies or clinical controlled studies were included, involving a total of 578 patients. Compared with single-stage excision, multiple-staged excision was associated with a significantly lower incidence of major wound complications (odds ratio (OR) = 0.54, 95% CI 0.30-0.97, = 0.04), lower recurrence rate (OR = 0.45, 95% CI 0.22-0.93, = 0.03), shorter scar length (MD = -0.32 mm, 95% CI -0.52 to -0.12, = 0.002), and narrower scar width (MD = -0.04 mm, 95% CI -0.09 to -0.01, = 0.04); the upper limit of the 95% CI was rounded to 0.00 by RevMan, while the unrounded value remained below zero. No significant differences were observed between the two groups in cosmetic satisfaction (OR = 1.07, 95% CI 0.64-1.79, = 0.80) or patient satisfaction (OR = 1.29, 95% CI 0.51-3.29, = 0.59). CONCLUSIONS: This meta-analysis demonstrates that multiple-staged excision significantly reduces the incidence of major wound complications, recurrence rate, and scar dimensions compared with single-stage excision, while showing no significant difference in satisfaction outcomes. These findings suggest that multiple-staged excision may offer advantages in safety and efficacy in the excision and reconstruction of CMN and could be considered a valuable surgical strategy in appropriate clinical settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.